Targeting inflammation in cystic fibrosis.

  title={Targeting inflammation in cystic fibrosis.},
  author={Elisabeth Kieninger and Nicolas Regamey},
  journal={Respiration; international review of thoracic diseases},
  volume={79 3},
disease, such as n –3 polyunsaturated fatty acids, receptor antagonists of the cysteinyl leukotrienes, macrolides, N acetylcysteine, and -1 antitrypsin have shown clinical efficacy or potential for clinical use, but to date no ideal anti-inflammatory agent for CF lung disease has been found [10] . Because of the notable side effects of broad-spectrum anti… CONTINUE READING